Full Text
The Expected Health Economic Value of Using Circulating Tumor Cells to Personalize Cancer Treatment

Abstract

Authors

K. Schreuder J.M. Hummel L.W. Terstappen M.J. Ijzerman

Back to Volume 16, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×